F. Léger
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Laurent Nguyen (3 shared papers)C. Puozzo (3 shared papers)Shari Lennon (2 shared papers)Annick Rousseau (3 shared papers)Pierre Marquet (3 shared papers)Gilles Paintaud (2 shared papers)Yannick Le Meur (2 shared papers)Étienne Chatelut (5 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)European Journal of Clinical Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Bone Marrow Transplantation (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- FranceNetherlandsGermany
In The Last Decade
F. Léger
11 papers receiving 482 citations
Peers
Comparison fields: 5 of 61
- Transplantation 104
- Hematology 139
- Pharmacology 45
- Pharmacology 68
- Oncology 104
Countries citing papers authored by F. Léger
This map shows the geographic impact of F. Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Léger more than expected).
Fields of papers citing papers by F. Léger
This network shows the impact of papers produced by F. Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Léger. The network helps show where F. Léger may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Léger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 114 | |
| 2 | 2005 | 93 | |
| 3 | 2004 | 78 | |
| 4 | 2002 | 49 | |
| 5 | 2004 | 38 | |
| 6 | 2004 | 32 | |
| 7 | 2003 | 28 | |
| 8 | 2002 | 24 | |
| 9 | 2009 | 22 | |
| 10 | 2003 | 9 | |
| 11 | 2006 | 7 | |
| 12 | 2010 | 1 |
About F. Léger
F. Léger is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health, Oncology, Hematology and Pharmacology, having authored 12 papers that have together received 495 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Lung Cancer Research Studies (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Transplantation (104 citations), Hematology (139 citations), Pharmacology (45 citations), Pharmacology (68 citations) and Oncology (104 citations). F. Léger has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include Laurent Nguyen, C. Puozzo, Shari Lennon, Annick Rousseau, Pierre Marquet, Gilles Paintaud, Yannick Le Meur, Étienne Chatelut, M. Büchler and Franck Saint‐Marcoux. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Bone Marrow Transplantation and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.